Ear involvement in acute promyelocytic leukemia at relapse: a disease-associated 'sanctuary'?

被引:27
作者
Breccia, M
Petti, MC
Testi, AM
Specchia, G
Ferrara, F
Diverio, D
Romano, A
Guerrisi, V
Greco, A
Fiorella, ML
de Vincentis, M
Mandelli, F
Lo Coco, F
机构
[1] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, Rome, Italy
[2] Univ Roma La Sapienza, Dept Radiol, Rome, Italy
[3] Univ Roma La Sapienza, Dept Otorhinolaryngol, Rome, Italy
[4] Univ Bari, Dept Hematol, Bari, Italy
[5] Osp A Carolaretti, Dept Hematol, Naples, Italy
关键词
acute promyelocytic leukemia; ear localization; PML/RAR alpha; extramedullary APL;
D O I
10.1038/sj.leu.2402497
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Extramedullary (EM) involvement occurs infrequently in acute promyelocytic leukemia (APL) and usually involves skin and CNS. We describe seven patients (four observed at a single institution) who relapsed in various sites of the auditory apparatus, including the external canal and middle ear (temporal bone). Front-line treatment included ATRA and chemotherapy (six patients) or chemotherapy alone (one patient). Three patients had concomitant hematologic relapse, two had molecular relapse and two were in hematologic and molecular remission when ear localization was documented. Local symptoms that stimulated further diagnostic studies included ear bleeding/discharge in the first patient, but were mild in the others (hypoacusia, five patients; earache, two patients). Ear involvement by leukemia was documented by histological and/or molecular studies after local surgery in five cases, and by CT scan or NMR in the remaining patients. We suggest that the ear might represent a specific sanctuary for disease involvement in APL.
引用
收藏
页码:1127 / 1130
页数:4
相关论文
共 32 条
  • [1] Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy
    Asou, N
    Adachi, K
    Tamura, J
    Kanamaru, A
    Kageyama, S
    Hiraoka, A
    Omoto, E
    Akiyama, H
    Tsubaki, K
    Saito, K
    Kuriyama, K
    Oh, H
    Kitano, K
    Miyawaki, S
    Takeyama, K
    Yamada, O
    Nishikawa, K
    Takahashi, M
    Matsuda, S
    Ohtake, S
    Suzushima, H
    Emi, N
    Ohno, R
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (01) : 78 - 85
  • [2] Unusual sites of involvement by hematologic malignancies - Case 3. External auditory canal tumor: A rare chloroma in acute promyelocytic leukemia with a complete response to arsenic trioxide
    Au, WY
    Chan, GCF
    Chim, CS
    Shek, TW
    Ooi, GC
    Ho, WK
    Kwong, YL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (19) : 3993 - 3995
  • [3] All-trans retinoic acid regulates adhesion mechanism and transmigration of the acute promyelocytic leukaemia cell line NB-4 under physiologic flow
    Brown, DC
    Tsuji, H
    Larson, RS
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1999, 107 (01) : 86 - 98
  • [4] Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid:: Result of the randomized MRC trial
    Burnett, AK
    Grimwade, D
    Solomon, E
    Wheatley, K
    Goldstone, AH
    [J]. BLOOD, 1999, 93 (12) : 4131 - 4143
  • [5] EXTRAMEDULLARY MYELOID CELL TUMORS IN ACUTE NONLYMPHOCYTIC LEUKEMIA - A CLINICAL REVIEW
    BYRD, JC
    EDENFIELD, WJ
    SHIELDS, DJ
    DAWSON, NA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (07) : 1800 - 1816
  • [6] ACUTE PROMYELOCYTIC LEUKEMIA - FROM CLINIC TO MOLECULAR-BIOLOGY
    CHEN, SJ
    WANG, ZY
    CHEN, Z
    [J]. STEM CELLS, 1995, 13 (01) : 22 - 31
  • [7] DINOTO R, 1994, LEUKEMIA, V8, pS71
  • [8] Treatment of newly diagnosed acute promyelocytic leukemia without cytarabine
    Estey, E
    Thall, PF
    Pierce, S
    Kantarjian, H
    Keating, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (02) : 483 - 490
  • [9] A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia
    Fenaux, P
    Chastang, C
    Chevret, S
    Sanz, M
    Dombret, H
    Archimbaud, E
    Fey, M
    Rayon, C
    Huguet, F
    Sotto, JJ
    Gardin, C
    Makhoul, PC
    Travade, P
    Solary, E
    Fegueux, N
    Bordessoule, D
    San Miguel, J
    Link, H
    Desablens, B
    Stamatoullas, A
    Deconinck, E
    Maloisel, F
    Castaigne, S
    Preudhomme, C
    Degos, L
    [J]. BLOOD, 1999, 94 (04) : 1192 - 1200
  • [10] Fenaux P, 1997, SEMIN ONCOL, V24, P92